Evidence map›Paper›PMID 31317129›Full record

ArticleEClinicalMedicine

Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose.

Janice M Pettie, Thomas M Caparrotta, Robert W Hunter, Emma E Morrison, David M Wood, Paul I Dargan, Ruben H Thanacoody, Simon H L Thomas, Muhammad E M O Elamin, Ben Francis and 4 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Binankadsurin A fromNutrients · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Investigating a Novel Two-Bag N-Acetylcysteine Regimen for Acetaminophen Toxicity.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  16. Intravenous Acetylcysteine: What Should Replace the Prescott "Three-Bag" Protocol?Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. MRI Detection of HepaticBiomedicines · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Janice M PettieNPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.
Thomas M CaparrottaPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
Robert W HunterPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
Emma E MorrisonPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
David M WoodClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Paul I DarganClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ruben H ThanacoodyMedical Toxicology Centre, Institute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, UK.
Simon H L ThomasMedical Toxicology Centre, Institute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, UK.
Muhammad E M O ElaminMedical Toxicology Centre, Institute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, UK.
Ben FrancisDepartment of Biostatistics, Institute of Translational Medicine, University of Liverpool, UK.
David J WebbPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
Euan A SandilandsNPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.
Michael EddlestonPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
James W DearPharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, UK.
University of Edinburgh · GBNewcastle University · GBEdinburgh Royal Infirmary · GBGuy's and St Thomas' NHS Foundation Trust · GBKing's College London · GBUniversity of Liverpool · GB

Funding

Wellcome Trust 209562/Z/17/Z
6 · The paper itself

Abstract

backgroundAcetylcysteine (NAC) is effective at preventing liver injury after paracetamol overdose. The Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning (SNAP) Study demonstrated that a 12 h NAC regimen was associated with fewer adverse drug reactions compared with the standard 21 h regimen. Here, we describe the clinical effectiveness of the SNAP NAC regimen.

methodsThe SNAP regimen, consisting of intravenous NAC 100 mg/kg over 2 h then 200 mg/kg over 10 h, was introduced to treat all paracetamol overdose patients at the Royal Infirmary of Edinburgh, the Royal Victoria Infirmary, Newcastle and St Thomas' Hospital, London. Patient data were prospectively and systematically collected before and after the change in treatment (total patients N = 3340, 21 h N = 1488, SNAP N = 1852). Health record linkage was used to determine patient outcome after hospital discharge.

findingsThere was no difference in liver injury or liver synthetic dysfunction between regimens. Hepatotoxicity (peak ALT > 1000 U/L) occurred in 64 (4.3%) and 67 (3.6%) patients, respectively, in the 21 h and SNAP groups (absolute difference - 0.7%, 95% CI - 2.1 to 0.6). Multivariable logistic regression did not identify treatment regimen as an outcome-associated factor. No patients were readmitted to hospital with, or died from, liver failure within 30 days of discharge. Anti-histamine treatment (for NAC anaphylactoid drug reactions) was prescribed for 163 (11.0%) patients with the 21 h regimen and 37 (2.0%) patients with the SNAP regimen (absolute difference 9.0% (95% CI 7.3 to 10.7)).

interpretationIn clinical use the SNAP regimen has similar efficacy as standard therapy for preventing liver injury and produces fewer adverse reactions.

Indexed as

Acute liver failureALT, Alanine transaminase activityClinical practiceDrug-induced liver injuryINR, International normalised ratioMHRA, Medicines and Healthcare Products Regulatory Agency'sNACNAC, AcetylcysteineNAPQI, N‑acetyl‑p‑benzoquinone imineParacetamolRIE, Royal Infirmary of EdinburghRVI, The Royal Victoria Infirmary, NewcastleSNAP, Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol PoisoningSTH, St Thomas' Hospital, London

Identifiers

PMID31317129
PMCPMC6610779
OpenAlexW2936632214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.